Acceleron Pharma Inc. XLRN
Trading inactive
XLRN
Acceleron Pharma Inc. RXDX
Prometheus Biosciences, Inc. KRTX
Karuna Therapeutics, Inc. IMGN
ImmunoGen, Inc. BPMC
Blueprint Medicines Corporation CERE
Cerevel Therapeutics Holdings, Inc. ROIV
Roivant Sciences Ltd. CTLT
Catalent, Inc. WBA
Walgreens Boots Alliance, Inc. RETA
Reata Pharmaceuticals, Inc.
Acceleron Pharma Inc. RXDX
Prometheus Biosciences, Inc. KRTX
Karuna Therapeutics, Inc. IMGN
ImmunoGen, Inc. BPMC
Blueprint Medicines Corporation CERE
Cerevel Therapeutics Holdings, Inc. ROIV
Roivant Sciences Ltd. CTLT
Catalent, Inc. WBA
Walgreens Boots Alliance, Inc. RETA
Reata Pharmaceuticals, Inc.
Performance
| Periode | XLRN | RXDX | KRTX | IMGN | BPMC | CERE | ROIV | CTLT | WBA | RETA |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 0.00 % | 64.88 % | 92.87 % | 98.95 % | 39.99 % | 9.66 % | 68.10 % | 9.73 % | 7.35 % | 72.79 % |
| YTD | 0.00 % | 87.54 % | 4.79 % | 5.31 % | 48.46 % | 6.52 % | 55.71 % | 0.00 % | 30.36 % | 369.52 % |
| 1Y | 0.00 % | 576.55 % | 80.59 % | 726.32 % | 35.28 % | 87.88 % | 58.87 % | 28.45 % | 32.23 % | 424.85 % |
| 3Y | 0.00 % | 690.51 % | 185.72 % | 250.96 % | 111.64 % | 45.17 % | 258.29 % | -38.92 % | -63.06 % | 50.36 % |
| 5Y | 81.62 % | 690.51 % | 1 547.50 % | 1 083.14 % | 71.29 % | 277.82 % | 80.87 % | 3.27 % | -66.79 % | 196.35 % |
| 10Y | 435.34 % | 690.51 % | 1 547.50 % | 93.17 % | 335.16 % | 277.82 % | 80.87 % | 126.15 % | -85.50 % | 1 218.75 % |
| From the beginning | 794.20 % | 690.51 % | 1 547.50 % | 228.79 % | 586.06 % | 277.82 % | 80.87 % | 217.56 % | 3 640.13 % | 1 218.75 % |